• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Dianne M. Finkelstein, PhD


  • Fan L, Strasser-Weippl K, Li JJ, St Louis J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM, Goss PE.Breast cancer in China.Lancet Oncol. 2014 Jun;15(7):e279-e289.
  • Dwojak SM, Finkelstein DM, Emerick KS, Lee JH, Petereit DG, Deschler DG.Poor Survival for American Indians with Head and Neck Squamous Cell Carcinoma.Otolaryngology Head And Neck Surgery : Official Journal Of American Academy Of Otolaryngology Head And Neck Surgery. 2014 Apr 28.
  • Hill DA, Horick NK, Isaacs C, Domchek SM, Tomlinson GE, Lowery JT, Kinney AY, Berg JS, Edwards KL, Moorman PG, Plon SE, Strong LC, Ziogas A, Griffin CA, Kasten CH, Finkelstein DM.Long-term risk of medical conditions associated with breast cancer treatment.Breast Cancer Res Treat. 2014 May;145(1):233-43.
  • Lowery JT, Horick N, Kinney AY, Finkelstein DM, Garrett K, Haile RW, Lindor NM, Newcomb PA, Sandler RS, Burke C, Hill DA, Ahnen DJ.A randomized trial to increase colonoscopy screening in members of high-risk families in the colorectal cancer family registry and cancer genetics network.Cancer Epidemiol Biomarkers Prev. 2014 Apr;23(4):601-10.
  • Schaid DJ, Spraggs CF, McDonnell SK, Parham LR, Cox CJ, Ejlertsen B, Finkelstein DM, Rappold E, Curran J, Cardon LR, Goss PE.Prospective Validation of HLA-DRB1*07:01 Allele Carriage As a Predictive Risk Factor for Lapatinib-Induced Liver Injury.J Clin Oncol. 2014 Mar 31.
  • Finkelstein DM, Schoenfeld DA.A joint test for progression and survival with interval-censored data from a cancer clinical trial.Stat Med. 2014 Feb 6.
  • Liedke PE, Finkelstein DM, Szymonifka J, Barrios CH, Chavarri-Guerra Y, Bines J, Vasconcelos C, Simon SD, Goss PE.Outcomes of breast cancer in Brazil related to health care coverage: a retrospective cohort study.Cancer Epidemiol Biomarkers Prev. 2014 Jan;23(1):126-33.
  • Specht MC, Miller CL, Russell TA, Horick N, Skolny MN, O'Toole JA, Jammallo LS, Niemierko A, Sadek BT, Shenouda MN, Finkelstein DM, Smith BL, Taghian AG.Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression?.Breast Cancer Res Treat. 2013 Aug;140(3):485-94.
  • Sgroi DC, Carney E, Zarrella E, Steffel L, Binns SN, Finkelstein DM, Szymonifka J, Bhan AK, Shepherd LE, Zhang Y, Schnabel CA, Erlander MG, Ingle JN, Porter P, Muss HB, Pritchard KI, Tu D, Rimm DL, Goss PE.Prediction of late disease recurrence and extended adjuvant letrozole benefit by the HOXB13/IL17BR biomarker.Journal of the National Cancer Institute. 2013 Jul 17;105(14):1036-42.
  • Goss PE, Smith IE, O'Shaughnessy J, Ejlertsen B, Kaufmann M, Boyle F, Buzdar AU, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Chavarri-Guerra Y, Aktan G, Rappold E, Williams LS, Finkelstein DM, .Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial.Lancet Oncol. 2013 Jan;14(1):88-96.
  • Finkelstein DM, Schoenfeld DA.Correcting for Discretionary Treatment Crossover in an Analysis of Survival in the Breast International Group BIG 1-98 Trial by Using the Inverse Probability of Censoring Weighted Method.J Clin Oncol. 2011 Mar 20;29(9):1093-5.
  • Schoenfeld DA, Rajicic N, Ficociello LH, Finkelstein DM.A test for the relationship between a time-varying marker and both recovery and progression with missing data.Stat Med. 2011 Mar 30;30(7):718-24.
  • Schoenfeld DA, Rajicic N, Ficociello LH, Finkelstein DM.A test for the relationship between a time-varying marker and both recovery and progression with missing data.Stat Med. 2011 Jan 11.
  • Rajicic N, Cuschieri J, Finkelstein DM, Miller-Graziano CL, Hayden D, Moldawer LL, Moore E, O'Keefe G, Pelik K, Warren HS, Schoenfeld DA, .Identification and interpretation of longitudinal gene expression changes in trauma.PLoS ONE. 2010;5(12):e14380.
  • Rizvi I, Celli JP, Evans CL, Abu-Yousif AO, Muzikansky A, Pogue BW, Finkelstein D, Hasan T.Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer.Cancer Res. 2010 Nov 15;70(22):9319-28.
  • Moorman PG, Iversen ES, Marcom PK, Marks JR, Wang F, , Lee E, Ursin G, Rebbeck TR, Domchek SM, Arun B, Susswein L, Isaacs C, Garber JE, Visvanathan K, Griffin CA, Sutphen R, Brzosowicz J, Gruber S, Finkelstein DM, Schildkraut JM.Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis.Breast Cancer Res Treat. 2010 Nov;124(2):441-51.
  • Finkelstein DM, Wang R, Ficociello LH, Schoenfeld DA.A Score Test for Association of a Longitudinal Marker and an Event with Missing Data.Biometrics. 2010 Sep;66(3):726-32.
  • Nichols AC, Finkelstein DM, Faquin WC, Westra WH, Mroz EA, Kneuertz P, Begum S, Michaud WA, Busse PM, Clark JR, Rocco JW.Bcl2 and Human Papilloma Virus 16 as Predictors of Outcome following Concurrent Chemoradiation for Advanced Oropharyngeal Cancer.Clin Cancer Res. 2010 Apr 1;16(7):2138-46.
  • Crippa S, Fernández-Del Castillo C, Salvia R, Finkelstein D, Bassi C, Domínguez I, Muzikansky A, Thayer SP, Falconi M, Mino-Kenudson M, Capelli P, Lauwers GY, Partelli S, Pederzoli P, Warshaw AL.Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics.Clin Gastroenterol Hepatol. 2010 Feb;8(2):213-9.
  • Rajicic N, Finkelstein DM, Schoenfeld DA, .Analysis of the relationship between longitudinal gene expressions and ordered categorical event data.Stat Med. 2009 Sep 30;28(22):2817-32.
  • Schoenfeld DA, Hui Zheng , Finkelstein DM.Bayesian design using adult data to augment pediatric trials.Clin Trials. 2009 Aug;6(4):297-304.
  • Souglakos J, Philips J, Wang R, Marwah S, Silver M, Tzardi M, Silver J, Ogino S, Hooshmand S, Kwak E, Freed E, Meyerhardt JA, Saridaki Z, Georgoulias V, Finkelstein D, Fuchs CS, Kulke MH, Shivdasani RA.Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer.Br J Cancer. 2009 Aug 4;101(3):465-72.
  • Nisbet DR, Moses D, Gengenbach TR, Forsythe JS, Finkelstein DI, Horne MK.Enhancing neurite outgrowth from primary neurones and neural stem cells using thermoresponsive hydrogel scaffolds for the repair of spinal cord injury.J Biomed Mater Res A. 2009 Apr;89(1):24-35.
  • Neklason DW,Kerber RA,Nilson DB,Anton-Culver H,Schwartz AG,Griffin CA,Lowery JT,Schildkraut JM,Evans JP,Tomlinson GE,Strong LC,Miller AR,Stopfer JE,Finkelstein DM,Nadkarni PM,Kasten CH,Mineau GP,Burt RW.Common familial colorectal cancer linked to chromosome 7q31: a genome-wide analysis.Cancer Res. 2008 Nov 1;68(21):8993-7.
  • Matthews AG,Finkelstein DM,Betensky RA.Analysis of familial aggregation studies with complex ascertainment schemes.Stat Med. 2008 Oct 30;27(24):5076-92.
  • Kerber RA,Amos CI,Yeap BY,Finkelstein DM,Thomas DC.Design considerations in a sib-pair study of linkage for susceptibility loci in cancer.BMC Med Genet. 2008;9:64.
  • Bell DW,Brannigan BW,Matsuo K,Finkelstein DM,Sordella R,Settleman J,Mitsudomi T,Haber DA.Increased prevalence of EGFR-mutant lung cancer in women and in East Asian populations: analysis of estrogen-related polymorphisms.Clin Cancer Res. 2008 Jul 1;14(13):4079-84.
  • Alm El-Din MA,Hughes KS,Finkelstein DM,Betts KA,Yock TI,Tarbell NJ,Aisenberg AC,Taghian AG.Breast cancer after treatment of Hodgkin's lymphoma: risk factors that really matter.Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):69-74.
  • Tanabe KK, Lemoine A, Finkelstein DM, Kawasaki H, Fujii T, Chung RT, Lauwers GY, Kulu Y, Muzikansky A, Kuruppu D, Lanuti M, Goodwin JM, Azoulay D, Fuchs BC.Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis.JAMA. 2008 Jan 2;299(1):53-60.
  • Rao SR, Graubard BI, Schmid CH, Morton SC, Louis TA, Zaslavsky AM, Finkelstein DM.Meta-analysis of survey data: application to health services research.Health Services and Outcomes Research Methodology.;8:98-114.
  • Parmigiani G, Chen S, Iversen ES Jr, Friebel TM, Finkelstein DM, Anton-Culver H, Ziogas A, Weber BL, Eisen A, Malone KE, Daling JR, Hsu L, Ostrander EA, Peterson LE, Schildkraut JM, Isaacs C, Corio C, Leondaridis L, Tomlinson G, Amos CI, Strong LC, Berry DA, Weitzel JN, Sand S, Dutson D, Kerber R, Peshkin BN, Euhus DM.Validity of models for predicting BRCA1 and BRCA2 mutations.Ann Intern Med. 2007 Oct 2;147(7):441-50.
  • Tripanichkul W, Sripanichkulchai K, Duce JA, Finkelstein DI.17Beta-estradiol reduces nitrotyrosine immunoreactivity and increases SOD1 and SOD2 immunoreactivity in nigral neurons in male mice following MPTP insult.Brain Res. 2007 Aug 20;1164:24-31.
  • Troped PJ, Wiecha JL, Fragala MS, Matthews CE, Finkelstein DM, Kim J, Peterson KE.Reliability and validity of YRBS physical activity items among middle school students.Med Sci Sports Exerc. 2007 Mar;39(3):416-25.
  • Stephen AE, Roth SI, Fardo DW, Finkelstein DM, Randolph GW, Gaz RD, Hodin RA.Predictors of an accurate preoperative sestamibi scan for single-gland parathyroid adenomas.Arch Surg. 2007 Apr;142(4):381-6.
  • Taveras EM, Sobol AM, Hannon C, Finkelstein D, Wiecha J, Gortmaker SL.Youths' perceptions of overweight-related prevention counseling at a primary care visit.Obesity (Silver Spring). 2007 Apr;15(4):831-6.
  • Matthews AG, Finkelstein DM, Betensky RA.Multivariate logistic regression for familial aggregation in age at disease onset.Lifetime Data Analysis. 2007 Jun;13(2):191-209.
  • Shepard JL, Amatruda JF, Finkelstein D, Ziai J, Finley KR, Stern HM, Chiang K, Hersey C, Barut B, Freeman JL, Lee C, Glickman JN, Kutok JL, Aster JC, Zon LI.A mutation in separase causes genome instability and increased susceptibility to epithelial cancer.Genes Dev. 2007 Jan 1;21(1):55-9.
  • Finkelstein DM, Kubzansky LD, Goodman E.Social status, stress, and adolescent smoking.J Adolesc Health. 2006 Nov;39(5):678-85.
  • Rajicic N, Finkelstein DM, Schoenfeld DA,.Survival analysis of longitudinal microarrays.Bioinformatics. 2006 Nov 1;22(21):2643-9.
  • Wiecha JL, Finkelstein D, Troped PJ, Fragala M, Peterson KE.School vending machine use and fast-food restaurant use are associated with sugar-sweetened beverage intake in youth.J Am Diet Assoc. 2006 Oct;106:1624-30.
  • Ferrone CR, Finkelstein DM, Thayer SP, Muzikansky A, Fernandez-delCastillo C, Warshaw AL.Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma.J Clin Oncol. 2006 Jun 20;24(18):2897-902.
  • Matthews AG, Betensky RA, Anton-Culver H, Bowen D, Griffin C, Isaacs C, Kasten C, Mineau G, Nayfield S, Schildkraut J, Strong L, Weber B, Finkelstein DM.Analysis of co-aggregation of cancer based on registry data.Community Genet. 2006;9(2):87-92.
  • Ankerst DK, Finkelstein DM.Clinical Monitoring Based on Joint Models for Longitudinal Biomarkers and Event Times. In Crowley, J, Editor.Handbook of Statistics in Clinical Oncology. 2005 Dec 30;Macmillan Press:402-11.
  • Shepard JL, Amatruda JF, Stern HM, Subramanian A, Finkelstein D, Ziai J, Finley KR, Pfaff KL, Hersey C, Zhou Y, Barut B, Freedman M, Lee C, Spitsbergen J, Neuberg D, Weber G, Golub TR, Glickman JN, Kutok JL, Aster JC, Zon LI.A zebrafish bmyb mutation causes genome instability and increased cancer susceptibility.Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13194-9.
  • Amrein PC, Clark JR, Supko JG, Fabian RL, Wang CC, Colevas AD, Posner MR, Deschler DG, Rocco JW, Finkelstein DM, McIntyre JF.Phase I trial and pharmacokinetics of escalating doses of paclitaxel and concurrent hyperfractionated radiotherapy with or without amifostine in patients with advanced head and neck carcinoma.Cancer. 2005 Oct 1;104(7):1418-27.
  • Nguyen PL, Chakravarti A, Finkelstein DM, Hochberg FH, Batchelor TT, Loeffler JS.Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma.J Clin Oncol. 2005 Mar 1;23(7):1507-13.
  • Roberts TG, Goulart BH, Squitieri L, Stallings SC, Halpern EF, Chabner BA, Gazelle GS, Finkelstein SN, Clark JW.Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials.JAMA. 2004 Nov 3;292(17):2130-40.
  • Finkelstein DM, Muzikansky A, Schoenfeld DA.Comparing survival of a sample to that of a standard population.J Natl Cancer Inst. 2003 Oct 1;95(19):1434-9.
  • Ancukiewicz M, Finkelstein DM, Schoenfeld DA.Modelling the relationship between continuous covariates and clinical events using isotonic regression.Stat Med. 2003 Oct 30;22(20):3151-9.
  • Pauler DK, Finkelstein DM.Predicting time to prostate cancer recurrence based on joint models for non-linear longitudinal biomarkers and event time outcomes.Stat Med. 2002 Dec 30;21(24):3897-911.
  • Ettinger DS, Finkelstein DM, Ritch PS, Lincoln ST, Blum RH,.Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588).Lung Cancer. 2002 Sep;37(3):311-8.
  • Finkelstein DM, Goggins WB, Schoenfeld DA.Analysis of failure time data with dependent interval censoring.Biometrics. 2002 Jun;58(2):298-304.
  • Hodi FS, Soiffer RJ, Clark J, Finkelstein DM, Haluska FG.Phase II study of paclitaxel and carboplatin for malignant melanoma.Am J Clin Oncol. 2002 Jun;25(3):283-6.
  • Shannon KM, Lubratovich ML, Finkelstein DM, Smith BL, Powell SN, Seiden MV.Model-based predictions of BRCA1/2 mutation status in breast carcinoma patients treated at an academic medical center.Cancer. 2002 Jan 15;94(2):305-13.
  • Betensky RA, Finkelstein DM.Testing for dependence between failure time and visit compliance with interval-censored data.Biometrics. 2002 Mar;58(1):58-63.
  • Chakravarti A, Noll E, Black PM, Finkelstein DF, Finkelstein DM, Dyson NJ, Loeffler JS.Quantitatively determined survivin expression levels are of prognostic value in human gliomas.J Clin Oncol. 2002 Feb 15;20(4):1063-8.
  • DiRienzo AG, van Der Horst C, Finkelstein DM, Frame P, Bozzette SA, Tashima KT.Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial infections in a randomized prophylaxis trial of patients with advanced HIV infection.AIDS Res Hum Retroviruses. 2002 Jan 20;18(2):89-94.
  • Smith MR, Finkelstein JS, McGovern FJ, Zietman AL, Fallon MA, Schoenfeld DA, Kantoff PW.Changes in body composition during androgen deprivation therapy for prostate cancer.J Clin Endocrinol Metab. 2002 Feb;87(2):599-603.
  • McKee GT, Tambouret RH, Finkelstein D.A reliable method of demonstrating HER-2/neu, estrogen receptors, and progesterone receptors on routinely processed cytologic material.Appl Immunohistochem Mol Morphol. 2001 Dec;9(4):352-7.
  • McKee GT, Tambouret RH, Finkelstein D.Fine-needle aspiration cytology of the breast: Invasive vs. in situ carcinoma.Diagn Cytopathol. 2001 Jul;25(1):73-7.
  • Goggins WB, Finkelstein DM, Tsao H.Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma.Cancer. 2001 Feb 15;91(4):874-80.
  • Breathnach OS, Kwiatkowski DJ, Finkelstein DM, Godleski J, Sugarbaker DJ, Johnson BE, Mentzer S.Bronchioloalveolar carcinoma of the lung: recurrences and survival in patients with stage I disease.J Thorac Cardiovasc Surg. 2001 Jan;121(1):42-7.
  • Chaudhuri S, Cariappa A, Tang M, Bell D, Haber DA, Isselbacher KJ, Finkelstein D, Forcione D, Pillai S.Genetic susceptibility to breast cancer: HLA DQB*03032 and HLA DRB1*11 may represent protective alleles.Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11451-4.
  • Tsao H, Zhang X, Kwitkiwski K, Finkelstein DM, Sober AJ, Haluska FG.Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma.Arch Dermatol. 2000 Sep;136(9):1118-22.
  • Robins JM, Finkelstein DM.Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests.Biometrics. 2000 Sep;56(3):779-88.
  • Goggins WB, Finkelstein DM.A proportional hazards model for multivariate interval-censored failure time data.Biometrics. 2000 Sep;56(3):940-3.
  • Aisenberg AC, Finkelstein DM.Second malignancies in Hodgkin's disease.J Clin Oncol. 2000 May;18(10):2186-7.
  • Chakravatri A, Zehr EM, Zietman AL, Shipley WU, Goggins WB, Finkelstein DM, Young RH, Chang EL, Wu CL.Thymosin beta-15 predicts for distant failure in patients with clinically localized prostate cancer-results from a pilot study.Urology. 2000 May;55(5):635-8.
  • Myojin M, Choi NC, Wright CD, Wain JC, Harris N, Hug EB, Mathisen DJ, Lynch T, Carey RW, Grossbard M, Finkelstein DM, Grillo HC.Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study.Int J Radiat Oncol Biol Phys. 2000 Mar 1;46(4):927-33.
  • Ryan DP, Lynch TJ, Grossbard ML, Seiden MV, Fuchs CS, Grenon N, Baccala P, Berg D, Finkelstein D, Mayer RJ, Clark JW.A phase I study of gemcitabine and docetaxel in patients with metastatic solid tumors.Cancer. 2000 Jan 1;88(1):180-5.
  • Ikeda K, Ichikawa T, Wakimoto H, Silver JS, Deisboeck TS, Finkelstein D, Harsh GR, Louis DN, Bartus RT, Hochberg FH, Chiocca EA.Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses.Nat Med. 1999 Aug;5(8):881-7.
  • Finkelstein DM, Schoenfeld DA.Combining mortality and longitudinal measures in clinical trials.Stat Med. 1999 Jun 15;18(11):1341-54.
  • Duska LR, Penson R, Supko JG, Finkelstein DM, Makastorsis T, Gallagher J, Borden K, Goodman A, Fuller AF, Nikrui N, Seiden MV.A Phase I study of continuous infusion doxorubicin and paclitaxel chemotherapy with granulocyte colony-stimulating factor for relapsed epithelial ovarian cancer.Clin Cancer Res. 1999 Jun;5(6):1299-305.
  • Shebani KO, Souba WW, Finkelstein DM, Stark PC, Elgadi KM, Tanabe KK, Ott MJ.Prognosis and survival in patients with gastrointestinal tract carcinoid tumors.Ann Surg. 1999 Jun;229(6):815-21; discussion 822-3.
  • Ott MJ, Tanabe KK, Gadd MA, Stark P, Smith BL, Finkelstein DM, Souba WW.Multimodality management of Merkel cell carcinoma.Arch Surg. 1999 Apr;134(4):388-92; discussion 392-3.
  • Goggins WB, Finkelstein DM, Schoenfeld DA, Zaslavsky AM.A Markov chain Monte Carlo EM algorithm for analyzing interval-censored data under the Cox proportional hazards model.Biometrics. 1998 Dec;54(4):1498-507.
  • Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN.Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.J Natl Cancer Inst. 1998 Oct 7;90(19):1473-9.
  • Colby C, McAfee SL, Finkelstein DM, Spitzer TR.Early vs delayed administration of G-CSF following autologous peripheral blood stem cell transplantation.Bone Marrow Transplant. 1998 May;21(10):1005-10.
  • Krainer M, Silva-Arrieta S, FitzGerald MG, Shimada A, Ishioka C, Kanamaru R, MacDonald DJ, Unsal H, Finkelstein DM, Bowcock A, Isselbacher KJ, Haber DA.Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer.N Engl J Med. 1997 May 15;336(20):1416-21.
  • Finkelstein DM, Schoenfeld DA, Stamenovic E.Analysis of multiple failure time data from an AIDS clinical trial.Stat Med. 1997 Apr 30;16(8):951-61.
  • Aisenberg AC, Finkelstein DM, Doppke KP, Koerner FC, Boivin JF, Willett CG.High risk of breast carcinoma after irradiation of young women with Hodgkin's disease.Cancer. 1997 Mar 15;79(6):1203-10.
  • FitzGerald MG, Bean JM, Hegde SR, Unsal H, MacDonald DJ, Harkin DP, Finkelstein DM, Isselbacher KJ, Haber DA.Heterozygous ATM mutations do not contribute to early onset of breast cancer.Nat Genet. 1997 Mar;15(3):307-10.
  • FitzGerald MG, Harkin DP, Silva-Arrieta S, MacDonald DJ, Lucchina LC, Unsal H, O'Neill E, Koh J, Finkelstein DM, Isselbacher KJ, Sober AJ, Haber DA.Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population.Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8541-5.
  • Safrin S, Finkelstein DM, Feinberg J, Frame P, Simpson G, Wu A, Cheung T, Soeiro R, Hojczyk P, Black JR.Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study .Ann Intern Med. 1996 May 1;124(9):792-802.
  • Finkelstein DM, Williams PL, Molenberghs G, Feinberg J, Powderly WG, Kahn J, Dolin R, Cotton D.Patterns of opportunistic infections in patients with HIV infection.J Acquir Immune Defic Syndr Hum Retrovirol. 1996 May 1;12(1):38-45.
  • Fischl MA, Finkelstein DM, He W, Powderly WG, Triozzi PL, Steigbigel RT.A phase II study of recombinant human interferon-alpha 2a and zidovudine in patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group.J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Apr 1;11(4):379-84.
  • FitzGerald MG, MacDonald DJ, Krainer M, Hoover I, O'Neil E, Unsal H, Silva-Arrieto S, Finkelstein DM, Beer-Romero P, Englert C, Sgroi DC, Smith BL, Younger JW, Garber JE, Duda RB, Mayzel KA, Isselbacher KJ, Friend SH, Haber DA.Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer.N Engl J Med. 1996 Jan 18;334(3):143-9.
  • Bozzette SA, Finkelstein DM, Spector SA, Frame P, Powderly WG, He W, Phillips L, Craven D, van der Horst C, Feinberg J.A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.N Engl J Med. 1995 Mar 16;332(11):693-9.
  • Finkelstein DM, Schoenfeld DA.Analysing survival in the presence of an auxiliary variable.Stat Med. 1994 Sep 15;13(17):1747-54.
  • Cotton DJ, Finkelstein DM, He W, Feinberg J.Determinants of accrual of women to a large, multicenter clinical trials program of human immunodeficiency virus infection. The AIDS Clinical Trials Group.J Acquir Immune Defic Syndr. 1993 Dec;6(12):1322-8.
  • Finkelstein DM, Moore DF, Schoenfeld DA.A proportional hazards model for truncated AIDS data.Biometrics. 1993 Sep;49(3):731-40.
  • Schoenfeld DA, Finkelstein DM, Richman DD.Designing phase II studies of chemotherapy for HIV infection using CD4 as an end-point.AIDS. 1993 Jul;7(7):955-8.
  • Hardy WD, Feinberg J, Finkelstein DM, Power ME, He W, Kaczka C, Frame PT, Holmes M, Waskin H, Fass RJ.A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021.N Engl J Med. 1992 Dec 24;327(26):1842-8.
  • Finkelstein DM.Modeling the effect of dose on the lifetime tumor rate from an animal carcinogenicity experiment.Biometrics. 1991 Jun;47(2):669-80.
  • Peteet JR, Murray-Ross D, Medeiros C, Walsh-Burke K, Rieker P, Finkelstein D.Job stress and satisfaction among the staff members at a cancer center.Cancer. 1989 Aug 15;64(4):975-82.
  • Finkelstein DM, Schoenfeld DA.Analysis of multiple tumor data from a rodent carcinogenicity experiment.Biometrics. 1989 Mar;45(1):219-30.
  • Finkelstein DM, Cassileth BR, Bonomi PD, Ruckdeschel JC, Ezdinli EZ, Wolter JM.A pilot study of the Functional Living Index-Cancer (FLIC) Scale for the assessment of quality of life for metastatic lung cancer patients. An Eastern Cooperative Oncology Group study.Am J Clin Oncol. 1988 Dec;11(6):630-3.
  • Finkelstein DM.A proportional hazards model for interval-censored failure time data.Biometrics. 1986 Dec;42(4):845-54.
  • Finkelstein DM, Ettinger DS, Ruckdeschel JC.Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study.J Clin Oncol. 1986 May;4(5):702-9.
  • Finkelstein DM, Wolfe RA.A semiparametric model for regression analysis of interval-censored failure time data.Biometrics. 1985 Dec;41(4):933-45.
  • Ruckdeschel JC, Finkelstein DM, Mason BA, Creech RH.Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V--a randomized comparison of four cisplatin-containing regimens.J Clin Oncol. 1985 Jan;3(1):72-9.